Isodiol International Inc.
Isodiol International Inc. ("Isodiol") is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions.
Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its consumer products portfolio and continued international expansion into Latin America, Asia, and Europe.
Isodiol International Inc. (ISOL)
Le 6 décembre/December 2021
The common shares of Isodiol International Inc. will be delisted at the market close today December 6, 2021.
Isodiol International is currently suspended. See bulletin 2020-1214.
Les actions ordinaires de Isodiol International Inc. seront radiées de la cote à la clôture du marché aujourd'hui, le 6 décembre 2021.